CSIMarket


Casi Pharmaceuticals inc.  (CASI)
Other Ticker:  
 


 

Casi Pharmaceuticals inc.

CASI's Financial Statements and Analysis



Casi Pharmaceuticals inc. increased II. Quarter net loss per share of $-0.56 compare to net loss per share of $-0.05 recorded in the same quarter a year ago a decrease compare to $-0.06 realized in previous quarter.


II. Quarter
Earnings Per Share Revenues
$ -0.56 $  9 Mill
$-0.51     $+1M     +19.7 %



Casi Pharmaceuticals's Revenue rose by 19.7 % in II. Quarter (Jun 30 2022) year on year, to $9 million and declined by -5.4 % sequentially.


Casi Pharmaceuticals is Expected to report next financial results on November 11, 2022.

More on CASI's Income Statement



Casi Pharmaceuticals's in II. Quarter recorded net loss of $-7.493 million, an increase from net loss of $-6.744 million in II. Quarter a year ago.

Sequentially net loss narrowed from net loss of $-8.400 million realized in previous quarter.

More on CASI's Growth

Inventories grew by 66.65 % to $6 million from II. Quarter a year ago, sequentially inventories rose by 55.63 %. In II. Quarter company's net cash and cash equivalents decreased by $-10 million, capital expenditures grew by -350.66%, to $1 millions compare to same quarter a year ago and rose by -124.87% from I. Quarter (Mar 31 2022).

More on CASI's Cash flow Statement


Casi Pharmaceuticals inc. does not pay out common stock dividend.

In trailing twelve-month period Casi Pharmaceuticals inc. payed $ -1.85 cash per share, on a free-cash flow basis .

Book value grew by 805.13 % sequentially to $4.92 per share.
Tangible Book value grew to $ 4.12 per share from $ 0.46.

Company repurchased 124.35 million shares or 90.14 % in II. Quarter.


More on CASI's Dividends

 Market Capitalization (Millions) 35
 Shares Outstanding (Millions) 14
 Total Debt (Millions $) 1
 Revenue (TTM) (Millions $) 35
 Net Income (TTM) (Millions $) -31
 Cash Flow (TTM) (Millions $) -42
 Capital Exp. (TTM) (Millions $) -9
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -




Casi Pharmaceuticals inc. does not pay out common stock dividend.

In trailing twelve-month period Casi Pharmaceuticals inc. payed $ -1.85 cash per share, on a free-cash flow basis .

Book value grew by 805.13 % sequentially to $4.92 per share.
Tangible Book value grew to $ 4.12 per share from $ 0.46.

Company repurchased 124.35 million shares or 90.14 % in II. Quarter.


More on CASI's Balance Sheets

 Market Capitalization (Millions) 35
 Shares Outstanding (Millions) 14
 Total Debt (Millions $) 1
 Revenue (TTM) (Millions $) 35
 Net Income (TTM) (Millions $) -31
 Cash Flow (TTM) (Millions $) -42
 Capital Exp. (TTM) (Millions $) -9
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -


   



       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

RELI's Profile

Stock Price

RELI's Financials

Business Description

Fundamentals

Charts & Quotes

RELI's News

Suppliers

RELI's Competitors

Customers & Markets

Economic Indicators

RELI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright Š 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071